4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-18-061329
President and CEO sold 18,333 shares at an average $18.43 ($337,938)
- President and CEO gave 40,000 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2018-11-27 | Gift | −40,000 | 2,689,304 | I | ||
| Watts Ryan J. President and CEO | 2018-12-03 | Sale | −17,933 | $18.42 | $330,274 | 2,671,371 | I |
| Watts Ryan J. President and CEO | 2018-12-03 | Sale | −400 | $19.16 | $7,664 | 2,670,971 | I |
| Open-market sales · 18,333 sh · avg $18.43 · $337,938 | |||||||
Loading xslF345X03/doc4.xml…